Not a member yet? Register here
Health of Tomorrow
Chemotherapy should be delayed in AML patients diagnosed with COVID-19
Index latest issue
Immune dysregulation in MDS and MPN:
An immunological mess
– Part 1
BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1
Diagnosis and treatment of Waldenström Macroglobulinaemia
Systemic bevacizumab to treat refractory bleeding in hereditary haemorrhagic telangiectasia: A single centre case series
Outpatient management of patients with acute myeloid leukaemia during intensive consolidation chemotherapy: A feasibility study
New haematology reimbursements in Belgium
Breakthrough COVID-19 in vaccinated patients with haematologic malignancies
Thrombopoietin is elevated during COVID-19 and is associated with platelet activation
Humoral responses against SARS-CoV-2 and variants of concern after vaccination in patients wit...
Elevated thrombopoietin levels may serve as biomarker for high risk of severe COVID-19
Prophylaxis with low-molecular-weight heparin has no benefit for at-risk outpatients with COVI...
Antibody response after vaccination against SARS-CoV-2 in patients with haematological maligna...
Managing COVID-19 disease in patients with haematologic malignancies: A clinical challenge
Vaccinated blood cancer patients show strong T-cell response